4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001140361-17-034333
President & CEO sold 15,000 shares at $37.21 ($558,150)
- President & CEO acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Abdun-Nabi Daniel · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-08-31 | Exercise or conversion : show line 1 in the form | +15,000 | $22.03 | $330,450 | 219,134 | D |
| 2017-08-31 | Sale : show line 2 in the form | −15,000 | $37.21 | $558,150 | 204,134 | D |
| Open-market sales · 15,000 sh · avg $37.21 · $558,150 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-08-31 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −15,000 | 26,508 | D |
Loading xslF345X03/doc1.xml…